Alchemab Therapeutics

14 posts

Alchemab Therapeutics

@alchemabtx

Katılım Mart 2020

6 Takip Edilen388 Takipçiler

Alchemab Therapeutics@alchemabtx·14 Haz

We are THRILLED to have been awarded ‘best biotech start-up’ as part of the OBN (UK) Ltd Awards! The award is really a reflection of our fantastic, dedicated and diverse team - all of whom have contributed to making this possible. #biotech #OBNAwards #startups

English

Alchemab Therapeutics@alchemabtx·5 May

Alchemab partnering with AstraZeneca to advance prostate cancer therapies #antibodies #drugdiscovery #prostatecancer #biotech lnkd.in/ddBWh-H

English

Alchemab Therapeutics@alchemabtx·16 Nis

We are thrilled to announce that we’ve raised £60m ($82m) in Series A funding led by RA Capital Management, with Lightstone Ventures and DHVC, joined by existing investors DCVC Bio, Dementia Discovery Fund and SV Health Investors who led the Seed round. lnkd.in/dX7YgnD

English

Alchemab Therapeutics@alchemabtx·16 Mar

Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington’s disease with Innovate UK grant Exciting scientific and advanced analytic/bioinformatic opportunities to join the team – see lnkd.in/d99PXQ6 lnkd.in/dgahkxH

English

Alchemab Therapeutics@alchemabtx·9 Mar

#WomenInScience #InternationalWomensDay

QME

Alchemab Therapeutics@alchemabtx·27 Kas

We’re excited to announce our partnership with @IMI_EPAD! Together we will uncover new science and further the discovery of innovative treatments for Alzheimer’s Disease

EPAD@IMI_EPAD

The EPAD Bioresource consists of over 100,000 samples. We’ve sent out our first batch of samples to an external partner @alchemabtx. We’re excited that the Longitudinal Cohort Study continues to be an important resource which generates new #data for #Alzheimer’s disease #research

English

Alchemab Therapeutics@alchemabtx·13 Kas

Delighted to have been added to the list of most disruptive companies in Cambridge - bit.ly/2K3056R @businessweekly - thank you for the recognition!

Business Weekly@businessweekly

Ten companies promoted to our list of the most disruptive life science and technology companies in Cambridge – The Killer50 bit.ly/2K3MZpV Killer50 companies have been involved in transactions worth more than $46.2bn in the last 12 months.

English

Alchemab Therapeutics@alchemabtx·10 Kas

Very proud to feature two of Alchemab's team in this year’s Movers and Shakers in BioBusiness report, Jane Osbourn OBE and Olivia Cavlan. Congratulations to Miranda Weston-Smith and the BioBeat team for compiling such a super report! lnkd.in/dmdGUKC

BioIndustry Association (BIA)@BIA_UK

Released today by @BioBeatUK, the 2020 Movers and Shakers in BioBusiness report highlights 30 examples of leaders in the UK bioscience sector. Congratulations to the scientists, financial experts, collaborators, innovators, and infrastructure specialists. mws-consulting.co.uk/publication/mo…

English

Alchemab Therapeutics retweetledi

BioIndustry Association (BIA)@BIA_UK·29 Eki

The UK BIA #AntibodyTaskforce is a world-leading consortium of biotech companies, charities and academia based across the UK who share a joint commitment to help fight the #COVID19 pandemic. #COVID19Antibodies Find out more👇 biacovid19.org/antibodies.html

BioIndustry Association (BIA) tweet media

English

Alchemab Therapeutics retweetledi

BioIndustry Association (BIA)@BIA_UK·29 Eki

Today we announce that the UK BIA #AntibodyTaskforce has identified antibodies with great potential to treat and protect against #COVID19, differentiated antibody combinations will be taken forward for further development as an antibody cocktail.👇 bia.me/37Ojv9b

English

Alchemab Therapeutics@alchemabtx·29 Eyl

We are delighted to announce a partnership between Alchemab and the Alberta Machine Intelligence Institute (Amii), a global leader in machine intelligence . amii.ca/latest-from-am…

English

Alchemab Therapeutics@alchemabtx·11 Eyl

Alchemab is delighted to be nominated as a finalist in the ‘Best Start-Up Biotech’ category for this year’s OBN Awards which recognises outstanding achievement in life sciences. Huge congratulations to our super team for their hard work and dedication over the last few months!

English

Alchemab Therapeutics@alchemabtx·14 Ağu

Jane Osbourn OBE, our CSO, will be speaking as the next guest on Rock Stars of R&D! See details below if you’d like to join to listen this Friday, August 14, 2020 at 7pm BST: lnkd.in/dt7b94w

English

Alchemab Therapeutics@alchemabtx·16 Tem

Alchemab is proud to be part of the Oxford BioEscalator cohort working on therapeutics against #COVID19 bioescalator.ox.ac.uk/news/agile-sta…

BioEscalator@BioEscalator

Aglie start-ups partner with academics to find covid-19 solutions @BioEscalator @NucleomeTx @DM_Jeziorska @alchemabtx #Hutanodiagnostics @OxfordMedSci @OxUInnovation @OxfordshireLEP @enterprisingox @Dunn_School @UnivofGh @MRC_WIMM #COVID19 #innovation bioescalator.ox.ac.uk/news/agile-sta…

English

Keşfet

@IMI_EPAD @businessweekly @elonmusk @BarackObama @taylorswift13 @cristiano @BillGates @NASA